| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615225 | Journal of Clinical Lipidology | 2017 | 37 Pages |
Abstract
Novel lipid-lowering agents have potential to improve the performance of LA, but more evidence is needed. The Multidisciplinary International Group for Hemapheresis TherapY and Metabolic DIsturbances Contrast scientific society aims to establish an international registry of clinical experience on LA combination therapy to expand the evidence on this treatment in individuals at high cardiovascular disease risk.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Claudia MD, PhD, Ulrich MD, Gerald F. MD, PhD, DSc, FRACP, FRCP (Lond), Mariko MD, PhD, Maria MD, Volker J. MD, Priv Doz, Giustina MD, Handrean MD, FRCP, MSc, MRCP, MBChB, Jeanine Roeters MD, PhD, Livia MD, PhD, Hans U. MD, Kurt MD, Patrick M. MD, PhD,